Amid rising lifestyle-related health concerns expert cautions routine health screenings may overlook early metabolic warning ...
Wondering whether your blood test result can be impacted because of periods Find out what our expert has to say ...
POTOMAC trial subgroup analyses suggest favorable trends in delaying high-risk events and cystectomy with the addition of durvalumab to BCG I+M in patients with high-risk NMIBC, with manageable safety ...
US President Donald Trump underwent another medical examination at Walter Reed National Military Medical Center ahead of ...
Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of ...
Growing body of clinical and real-world evidence supports the role of Rezdiffra® (resmetirom) as the foundational therapy for patients with MASH ...
As a rare strain of Ebola virus continues to spread in the Democratic Republic of Congo and Uganda, here's what Canadians ...
Data reinforce WVE-006's potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with mo ...
(Nasdaq: GILD) today shared new results from a post hoc analysis showing that Livdelzi ® (seladelpar) was associated with high and sustained rates of normalization of a key liver marker (ALP) in ...
Pfizer Inc. (NYSE: PFE) today announced unprecedented seven-year follow-up results from the Phase 3 CROWN trial evaluating LORBRENA ® (lorlatinib, a third-generation ALK inhibitor, available in Europe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results